電子治験マスターファイル (eTMF) システムの世界市場予測（～2024年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 16)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 25)
4 Premium Insights (Page No. – 28)
4.1 Electronic Trial Master File (eTMF) Systems: Market Overview
4.2 Geographic Analysis: North American eTMF Market, By Delivery Mode
4.3 Us: eTMF Systems Market Share, By Component and Delivery Mode
4.4 Geographical Snapshot of the eTMF Systems Market
5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Adoption of eTMF Systems
5.2.1.2 Rising Number of Clinical Trials
5.2.1.3 Rising Government Funding and Grants to Support Clinical Trials
5.2.1.4 Increasing R&D Expenditure By Pharma-Biotech Companies and It Expenditure Allocations
5.2.2 Restraints
5.2.2.1 Budget Constraints
5.2.3 Opportunities
5.2.3.1 Emerging Asian Markets
5.2.4 Challenges
5.2.4.1 Clinical Data Privacy
5.2.4.2 Dearth of Skilled Professionals for Operating eTMF Systems
6 eTMF Systems Market, By Component (Page No. – 37)
6.1 Introduction
6.2 Services
6.2.1 Reliance on Services Will Remain High in the Coming Years, Ensuring Strong Growth in Demand
6.3 Software
6.3.1 Rising Adoption of Software is Driving High Growth in the Market
7 eTMF Systems Market, By Delivery Mode (Page No. – 43)
7.1 Introduction
7.2 Cloud-Based eTMF
7.2.1 Cloud-Based eTMF Segment to Register Higher Growth During the Forecast Period
7.3 On-Premise eTMF
7.3.1 Lack of Remote Access Capabilities to Restrain the Demand for On-Premise eTMF
8 eTMF Systems Market, By End User (Page No. – 48)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Pharmaceutical & Biotechnology Companies are Major End Users of eTMF Systems
8.3 Contract Research Organizations
8.3.1 Increasing Outsourcing of Clinical Trials By Pharmaceutical & Biotechnology Companies to Cros is Driving the Adoption of eTMF Systems
8.4 Other End Users
9 Electronic Trial Master File (eTMF) Systems Market, By Region (Page No. – 57)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Favorable Government Funding Scenario and A Large Number of Ongoing Clinical Trials are Driving the Adoption of eTMF Systems in the US
9.2.2 Canada
9.2.2.1 Favorable Regulatory Conditions and Growing Partnerships in Canada to Support Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany to Register the Highest Growth in the European eTMF Systems Market During the Forecast Period
9.3.2 UK
9.3.2.1 Growing Number of Biopharmaceutical and Medical Device Companies to Propel the Adoption of eTMF Systems in the UK
9.3.3 France
9.3.3.1 Rising Focus on Biosimilars to Create A Potential Market for eTMF Systems in France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Growing Outsourcing of Clinical Trials to Cros to Support Market Growth in China
9.4.2 Japan
9.4.2.1 Government Initiatives and Partnerships Among Pharmaceutical Companies and Cros to Drive Market Growth in Japan
9.4.3 Rest of Asia Pacific
9.5 Rest of the World
10 Competitive Landscape (Page No. – 84)
10.1 Overview
10.2 Market Ranking of Players, 2018
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Scenario
10.4.1 Solution Deployments
10.4.2 Solution Enhancements
10.4.3 Expansions
10.4.4 Partnerships
11 Company Profiles (Page No. – 91)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Veeva Systems
11.2 Oracle Corporation
11.3 Phlexglobal
11.4 Transperfect
11.5 Aurea Software
11.6 Labcorp
11.7 Epharmasolutions
11.8 Wingspan Technology
11.9 Mastercontrol
11.1 Sureclinical
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 106)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details